Day: June 3, 2022

– Less than 1 in 10 were on any non-statin lipid lowering therapy – – Findings were shared at the National Lipid Association Scientific Sessions – ANN ARBOR, Mich., June 03, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced findings from a real-world analysis of more than 400,000 patients at high-risk for atherosclerotic cardiovascular disease (ASCVD). The findings were presented at the National Lipid Association Scientific Sessions in Scottsdale, Arizona. “While professional guidelines are clear on defining appropriate lipid-lowering therapies for individuals at high-risk for ASCVD based on LDL-cholesterol, this analysis demonstrates major shortfalls in the real-world application of those guidelines,” said JoAnne Foody, MD, FACC, FAHA, chief medical officer of Esperion. “While LDL-cholesterol as a cardiovascular risk factor...

Ålandsbanken Abp  Changes in company’s own shares03.06.2022 at 18:30 EET Ålandsbanken Abp: Acquisitions of own shares 03.06.2022Date 03.06.2022  ExchangeBourse trade   Nasdaq Helsinki Oy (XHEL)Buy  Share class ALBBV  Amount             890  Average price/share 30,3933 EURHighest price/share 30,4000 EURLowest price/share 30.3000 EURTotal price 27,050.04 EUR     The shares held by Ålandsbanken Abp on 03.06.2022:    ALBBV  4971  On behalf of Ålandsbanken Abp Skandinaviska Enskilda Banken AB (Publ) Antti Salakka                      Janne Tiihonen For more information, please contact: Peter Wiklöf, Managing Director and Chief Executive, Bank of Åland Plc, tel +358...

COPENHAGEN, Denmark – June 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) will host an investor and analyst conference call on Tuesday, June 7, 2022, at 3:00 pm CEST (9:00 am EDT) to provide a general update on the Company’s business in relation to the ongoing monkeypox outbreak. President & CEO, Paul Chaplin and EVP and CFO, Henrik Juuel will give a presentation covering topics such as the monkeypox disease and the current outbreak, regulatory status and official recommendations on the use of the Company’s smallpox/monkeypox vaccine, and the interactions with countries and organizations worldwide on vaccine supply in both the short and long term and its impact on the Company’s business and guidance. The presentation will be followed by a Q&A session. A live and replay version of the call and relevant slides will be available...

FREEHOLD, NJ, June 03, 2022 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) today announced that Samuel A. Landy, President and Chief Executive Officer, Anna T. Chew, Vice President and Chief Financial Officer, and Eugene W. Landy, Chairman of the Board, are scheduled to participate in Nareit’s REITweek: 2022 Investor Conference, to be held in New York City, at the New York Hilton Midtown. UMH’s senior management team is scheduled to present on Wednesday, June 8, 2022, at 9:30 a.m. Eastern Time. The presentation will be available live via webcast and accessible at the Company’s website, www.umh.reit, in the Upcoming Events section. The webcast replay will be available for 30 days after the presentation. Presentation materials will also be available at the Company’s website homepage. UMH Properties, Inc., which was organized...

REGULATED INFORMATION                Paris, 3 June 2022 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Disclosure of Share Capital and Voting Rights Disclosure of Share Capital and Voting Rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. Register name of the issuer: TOUAX SCA (Euronext Paris: TOUP)Date Total shares outstanding Total voting rights Total exercisable voting rights*May 31, 2022 7,011,547 8,350,162 8,267,246* excluding rights attached to shares held in treasury **************** TOUAX Group leases out tangible assets (freight railcars, river barges and containers) on a daily basis throughout the world, for its own account and on behalf of third party investors. With €1.1 billion under...

  French public limited company (société anonyme) with a share capital of €1,491,929,810.00 Registered office : 1973, boulevard de la Défense 92000 Nanterre – France 552 037 806 RCS Nanterre www.vinci.com   DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MAY 2022    Total number of shares 596,771,924Theoretical number of voting rights (including treasury stock) 596,771,924Number of voting rights (excluding treasury stock) 564,895,683  This disclosure is on VINCI web site www.vinci.com (section investors/financial information/regulatory information/7. monthly information concerning the total number of voting rights and shares that make up the company’s capital).Attachment2022 05 31 ddv English version

Saint-Herblain (France), June 3, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Jefferies Healthcare Conference which will take place from June 8 to 10, 2022 in New York.  Valneva’s Chief Executive Officer Thomas Lingelbach and Chief Financial Officer Peter Bühler will notably discuss the Company’s late-stage vaccine candidates against Lyme disease (VLA15), chikungunya (VLA1553) and COVID-19 (VLA2001). Valneva was recently granted Conditional Marketing Authorization in the United Kingdom for its inactivated COVID-19 vaccine candidate VLA20011 and filed a Marketing Authorization Application with the European Medicines in May 20222. The Company also recently commenced the pre-submission...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 3, 2022 — Santhera Pharmaceuticals (SIX: SANN) has updated its corporate calendar. The Company will publish its 2021 Annual Report on June 10, 2022 and hold its Annual General Meeting on June 30, 2022. SIX Exchange Regulation has permitted Santhera to publish its annual report for the year ended December 31, 2021, on June 10, 2022. Following the successful completion of Santhera’s financing announced on June 2, 2022, Santhera is in the process of completing the 2021 annual report. Also, SIX Exchange Regulation has approved the listing of 15,500,000 existing treasury shares of Santhera as of Tuesday, June 7, 2022. DECISION OF SIX EXCHANGE REGULATION To allow for the finalization of the annual report, SIX Exchange Regulation has granted an extension for the...

Ageas: Transparency notification In accordance with the rules on financial transparency*, Ageas has notified on 3 June 2022 that, on 1 June 2022, its interest has exceeded the statutory threshold of 3% of the shares issued by Ageas. Its current shareholding stands at 3.01%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notification requirementSee annex 1a Date on which the threshold is crossed1 June 2022e Threshold that is crossed (in %)3% shares Denominator189,731,187 Notified detailsSee annex 1 b Chain of controlled undertakings through which the holding is effectively held, if applicableThe full chain of command can be found on https://www.ageas.com/investors/shareholders Additional informationThe shares related...

SOGECLAIRBusiness corporation with a capital of 3 204 901 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Information concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (‘“Règlement général de l’Autorité des Marchés Financiers”)DATE Total number of shares in the share capital Total number of voting rights31 May 2022 3,204,901 Total voting rights – brut: 5,355,854    Total voting rights – net*: 5,211,358* net total: total number of voting rights attached to the total number of shares –  shares deprived of voting rights (treasury stock etc.)Attachment...